Skip to main content
Log in

The Correlation Between the Subsets of Tumor Infiltrating Memory T Cells and the Expression of Indoleamine 2,3-Dioxygenase in Gastric Cancer

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Backgrounds

Although many researchers have concentrated on the mechanism of T cell anergy resulting from over-expression of Indoleamine 2,3-dioxygenase (IDO), it remains unclear what alterations will developed in memory T cells (Tm) under over-expression of IDO.

Methods

Immunohistochemical staining for IDO expression in gastric cancer tissues (n = 50) was carried out. Tumor-infiltrating memory Tm cells were counted by flow cytometry. The association between IDO expression and the subsets of tumor infiltrating Tm are discussed.

Results

The higher IDO expressions were significantly associated with deeper invasion (P = 0.016) and higher frequencies (P = 0.038) of lymph node metastasis. The lower tumor-infiltrating CD4+Tm were significantly associated with the advanced clinical stage (P = 0.026) and lymph node metastasis (P = 0.016). The lower percentages of CD8+Tm were significantly related to undifferentiated histological type (P = 0.042) and lymph node metastasis (P = 0.037). However, the lower percentage of CD8+Tem was significantly correlated to differentiated histological type (P = 0.017), lower frequencies of lymph node metastasis (P = 0.014), and earlier clinical stage (P = 0.008). The higher IDO expression patients had significantly lower percentages of CD4+Tm (P = 0.012) and CD8+Tm (P = 0.033). Nevertheless, it was confirmed that the higher level of IDO expression correlated with higher percentages of CD8+Tm cells in univariate and multivariate analysis (P = 0.011).

Conclusion

IDO over-expression and Tm in tumor microenvironments were correlated with the disease stage and histological type of gastric cancer. Higher IDO expression was related to the lower percentage of CD4+Tm and CD8+Tm, whereas the higher level of IDO expression related with a higher percentage of CD8+Tem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Whiteside TL. Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention. Semin Cancer Biol. 2006;16:3–15.

    Article  PubMed  CAS  Google Scholar 

  2. Takikawa O. Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolism. Biochem Biophys Res Commun. 2005;338:12–19.

    Article  PubMed  CAS  Google Scholar 

  3. Zhang R, Li H, Yu J, et al. Immunoactivative role of indoleamine 2,3dioxygenase in gastric cancer cells in vitro. Mol Med Report. 2011;4:169–173.

    CAS  Google Scholar 

  4. Yu J, Sun J, Wang SE, et al. Upregulated expression of indoleamine 2, 3-dioxygenase in primary breast cancer correlates with increase of infiltrated regulatory T cells in situ and lymph node metastasis. Clin Dev Immunol. 2011;2011:469135.

    Google Scholar 

  5. Astigiano S, Morandi B, Costa R, et al. Eosinophil granulocytes account for indoleamine 2,3-dioxygenase-mediated immune escape in human non-small cell lung cancer. Neoplasia. 2005;7:390–396.

    Article  PubMed  CAS  Google Scholar 

  6. Brandacher G, Perathoner A, Ladurner R, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res. 2006;12:1144–1151.

    Article  PubMed  CAS  Google Scholar 

  7. Munn DH, Shafizadeh E, Attwood JT, Bondarev I, Pashine A, Mellor AL. Inhibition of T cell proliferation by macrophage tryptophan catabolism. J Exp Med. 1999;189:1363–1372.

    Article  PubMed  CAS  Google Scholar 

  8. Li R, Wei F, Yu J, Li H, Ren X, Hao X. IDO inhibits T-cell function through suppressing Vav1 expression and activation. Cancer Biol Ther. 2009;8:1402–1408.

    Article  PubMed  CAS  Google Scholar 

  9. Fallarino F, Grohmann U, You S, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol. 2006;176:6752–6761.

    PubMed  CAS  Google Scholar 

  10. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401:708–712.

    Article  PubMed  CAS  Google Scholar 

  11. Manjunath N, Shankar P, Wan J, et al. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J Clin Invest. 2001;108:871–878.

    PubMed  CAS  Google Scholar 

  12. Wherry EJ, Teichgraber V, Becker TC, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol. 2003;4:225–234.

    Article  PubMed  CAS  Google Scholar 

  13. Klebanoff CA, Gattinoni L, Torabi-Parizi P, et al. Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells. Proc Natl Acad Sci USA. 2005;102:9571–9576.

    Article  PubMed  CAS  Google Scholar 

  14. Liu Z, Dai H, Wan N, et al. Suppression of memory CD8 T cell generation and function by tryptophan catabolism. J Immunol. 2007;178:4260–4266.

    PubMed  CAS  Google Scholar 

  15. Zamarron BF, Chen W. Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci. 2011;7:651–658.

    Article  PubMed  CAS  Google Scholar 

  16. Smyth MJ, Trapani JA. Lymphocyte-mediated immunosurveillance of epithelial cancers? Trends Immunol. 2001;22:409–411.

    Article  PubMed  CAS  Google Scholar 

  17. Inaba T, Ino K, Kajiyama H, et al. Indoleamine 2,3-dioxygenase expression predicts impaired survival of invasive cervical cancer patients treated with radical hysterectomy. Gynecol Oncol. 2010;117:423–428.

    Article  PubMed  CAS  Google Scholar 

  18. Huang TT, Yen MC, Lin CC, et al. Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer. Cancer Sci. 2011;102:2214–2220.

    Article  PubMed  CAS  Google Scholar 

  19. Ino K, Yamamoto E, Shibata K, et al. Inverse correlation between tumoral indoleamine 2,3-dioxygenase expression and tumor-infiltrating lymphocytes in endometrial cancer: its association with disease progression and survival. Clin Cancer Res. 2008;14:2310–2317.

    Article  PubMed  CAS  Google Scholar 

  20. Rauser S, Langer R, Tschernitz S, et al. High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma. BMC Cancer. 2010;10:608.

    Article  PubMed  CAS  Google Scholar 

  21. Pages F, Berger A, Camus M, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:2654–2666.

    Article  PubMed  CAS  Google Scholar 

  22. Broussard EK, Disis ML. TNM staging in colorectal cancer: T is for T cell and M is for memory. J Clin Oncol. 2011;29:601–603.

    Article  PubMed  Google Scholar 

  23. Nosho K, Baba Y, Tanaka N, et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol. 2010;222:350–366.

    Article  PubMed  Google Scholar 

  24. Hotta K, Sho M, Fujimoto K, et al. Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma. Br J Cancer. 2011;105:1191–1196.

    Article  PubMed  CAS  Google Scholar 

  25. Lee HE, Chae SW, Lee YJ, et al. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer. 2008;99:1704–1711.

    Article  PubMed  CAS  Google Scholar 

  26. Dai H, Dai Z. The role of tryptophan catabolism in acquisition and effector function of memory T cells. Curr Opin Organ Transplant. 2008;13:31–35.

    Article  PubMed  Google Scholar 

  27. Rohde J, Heitman J, Cardenas ME. The TOR kinases link nutrient sensing to cell growth. J Biol Chem. 2001;276:9583–9586.

    Article  PubMed  CAS  Google Scholar 

  28. Narasimhan J, Staschke KA, Wek RC. Dimerization is required for activation of eIF2 kinase Gcn2 in response to diverse environmental stress conditions. J Biol Chem. 2004;279:22820–22832.

    Article  PubMed  CAS  Google Scholar 

  29. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol. 2004;4:762–774.

    Article  PubMed  CAS  Google Scholar 

  30. Mondino A, Mueller DL. mTOR at the crossroads of T cell proliferation and tolerance. Semin Immunol. 2007;19:162–172.

    Article  PubMed  CAS  Google Scholar 

  31. Millan O, Jimenez O, Fortuna V, Barcelo JJ, Brunet M. Role of FK778 alone or in combination with tacrolimus or mTOR inhibitors as an immunomodulator of immunofunctions: in vitro evaluation of T cell proliferation and the expression of lymphocyte surface antigens. Int J Immunopathol Pharmacol. 2006;19:317–330.

    PubMed  CAS  Google Scholar 

  32. Nam JH. Rapamycin: could it enhance vaccine efficacy? Expert Rev Vaccines. 2009;8:1535–1539.

    Article  PubMed  CAS  Google Scholar 

  33. Wiesel M, Walton S, Richter K, Oxenius A. Virus-specific CD8 T cells: activation, differentiation and memory formation. Apmis. 2009;117:356–381.

    Article  PubMed  CAS  Google Scholar 

  34. Bassett JD, Swift SL, VanSeggelen H, et al. Combined mTOR inhibition and OX40 agonism enhances CD8(+) T cell memory and protective immunity produced by recombinant adenovirus vaccines. Mol Ther. 2012;20:860–869.

    Article  PubMed  CAS  Google Scholar 

  35. Jobim PF, Pedroso TR, Werenicz A, et al. Impairment of object recognition memory by rapamycin inhibition of mTOR in the amygdala or hippocampus around the time of learning or reactivation. Behav Brain Res. 2012;228:151–158.

    Article  PubMed  CAS  Google Scholar 

  36. Araki K, Turner AP, Shaffer VO, et al. mTOR regulates memory CD8 T-cell differentiation. Nature. 2009;460:108–112.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiubao Ren.

Additional information

This article concentrates on the impact of indoleamine 2,3-dioxygenase on infiltrating memory T cells in gastric cancer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, R., Liu, H., Li, F. et al. The Correlation Between the Subsets of Tumor Infiltrating Memory T Cells and the Expression of Indoleamine 2,3-Dioxygenase in Gastric Cancer. Dig Dis Sci 58, 3494–3502 (2013). https://doi.org/10.1007/s10620-013-2837-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-013-2837-0

Keywords

Navigation